Has Eric Zielinski received payments from drug or device companies?

Yes. Drug and device makers reported $6,999 in general payments to Eric Zielinski across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eric Zielinski did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eric Zielinski come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eric Zielinski

Plastic and Reconstructive Surgery · Chicago, ILNPI 1528599933

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Axogen at 24.1% of the total. 2025 is the largest year on record at $2,436, more than ten times the $83 reported in 2019.

$6,999in general payments, 2019–2025

Across 85 payments — averaging $82.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Axogen$2K
AbbVie$2K
TELA Bio, Inc.$975
Integra Lifesciences Corporation$404
Access Pro Medical, LLC$283
Mentor Worldwide LLC$273
plus $2K from 12 others

What the payments were for

Food & beverage$6,999100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Axogen	21	$1,688
AbbVie(2 entities)	21	$1,588
TELA Bio, Inc.	10	$975
Integra Lifesciences Corporation	4	$404
Access Pro Medical, LLC	2	$283
Mentor Worldwide LLC	5	$273
Davol Inc.	2	$230
Acera Surgical, Inc.	2	$219
Kerecis Limited	2	$213
Stryker	4	$205
Avita Medical Americas, LLC	2	$184
Baxter Healthcare	2	$165
Checkpoint Surgical, Inc	2	$149
Endo USA, Inc.	1	$136
BD	1	$117
Johnson & Johnson	1	$83
Motiva USA, LLC	1	$43
Sientra, Inc.	2	$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,999 in reported general payments places this provider in the 75th percentile of 126 plastic and reconstructive surgery providers in Illinois.

See all plastic and reconstructive surgery providers in Illinois →

Other plastic and reconstructive surgery in Chicago

John KimChicago$7.3M
Julius FewChicago$148K
Gregory DumanianChicago$50K
Stefan SzczerbaChicago$29K
Amir DorafsharChicago$29K
Michael HornChicago$14K
Lindsay JanesChicago$14K
Georgios KokosisChicago$13K
Cristin CoquillardChicago$13K
Brian BraithwaiteChicago$12K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →